Vascular endothelium in diabetes

American Journal of Physiology - Renal Physiology

Volumn 312, Issue 2, 2017, Pages F266-F275

  Goligorsky, Michael S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Endothelial glycocalyx; Lysosomal dysfunction; Nitric oxide; Premature cell senescence; Sirtuin 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; NITRIC OXIDE; SIRTUIN 1; VASCULOTROPIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

CELL AGING; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GLYCOCALYX; HUMAN; HYPERGLYCEMIA; MICROVASCULATURE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; VASCULAR ENDOTHELIUM; ANIMAL; METABOLISM; MICROCIRCULATION; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS;

EID: 85011976691     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00473.2016     Document Type: Review

References (60)

1. Aldini G, Vistoli G, Stefek M, Chondrogianni N, Grune T, Sereikaite J, Sadowska-Bartosz I, Bartosz G. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic Res 47, Suppl 1: 93–137, 2013. doi: 10.3109/ 10715762.2013.792926.
2. Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in patient with essential hypertension. Cardiovascular and renal implications (4th ed.). In: The Kidney and Hypertension in Diabetes Mellitus, edited by Mogensen CE. Boston, MA: Kluwer Academic Publ, 1998, p. 569–584. doi: 10.1007/ 978-1-4757-6752-0_53.
3. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti PS, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab 22: 86–99, 2015. doi: 10.1016/j.cmet.2015.05.012.
4. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS. Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 280: F480–F486, 2001.
5. Brodsky SV, Gao S, Li H, Goligorsky MS. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol 283: H2130–H21, 2002. doi: 10.1152/ ajpheart.00196.2002.
6. Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, Schlingemann RO, Nieuwdorp M, Stroes ES, Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 53: 2646–2655, 2010. doi: 10.1007/s00125-010-1910-x.
7. Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 57: 696–705, 2008. doi: 10.2337/db07-1098.
8. Chander PN, Gealekman O, Brodsky SV, Elitok S, Tojo A, Crabtree M, Gross SS, Goligorsky MS. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 15: 2391–2403, 2004. doi: 10.1097/01.ASN.0000135971.88164.2C.
9. Chen J, Xavier S, Moskowitz-Kassai E, Chen R, Lu CY, Sanduski K, Špes A, Turk B, Goligorsky MS. Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol 180: 973–983, 2012. doi: 10.1016/j.ajpath.2011.11.033.
10. Chen J, Brodsky S, Li H, Hampel DJ, Miyata T, Weinstein T, Gafter U, Norman JT, Fine LG, Goligorsky MS. Delayed branching of endo-thelial capillary-like cords in glycated collagen I is mediated by early induction of PAI-1. Am J Physiol Renal Physiol 281: F71–F80, 2001.
11. Chen J, Brodsky SV, Goligorsky DM, Hampel DJ, Li H, Gross SS, Goligorsky MS. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res 90: 1290–1298, 2002. doi: 10.1161/01.RES.0000022161.42655.98.
12. Chen J, Li H, Addabbo F, Zhang F, Pelger E, Patschan D, Park HC, Kuo MC, Ni J, Gobe G, Chander PN, Nasjletti A, Goligorsky MS. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. Am J Pathol 174: 701–711, 2009. doi: 10. 2353/ajpath.2009.080606.
13. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12: 993–1000, 2001.
14. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226, 1989. doi: 10. 1007/BF00285287.
15. Deckert T, Horowitz IM, Kofoed-Enevoldsen A, Kjellén L, Deckert M, Lykkelund C, Burcharth F. Possible genetic defects in regulation of glycosaminoglycans in patients with diabetic nephropathy. Diabetes 40: 764–770, 1991. doi: 10.2337/diab.40.6.764.
16. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de Kreutzenberg S, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26: 2140–2146, 2006. doi: 10.1161/01.ATV.0000237750.44469.88.
17. Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, Cabrelle A, Agostini C, Avogaro A. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49: 3075–3084, 2006. doi: 10.1007/s00125-006-0401-6.
18. Garsen M, Lenoir O, Rops AL, Dijkman HB, Willemsen B, van Kuppevelt TH, Rabelink TJ, Berden JH, Tharaux PL, van der Vlag J. Endothelin-1 induces proteinuria by heparanase-mediated disruption of the glomerular glycocalyx. J Am Soc Nephrol 27: 3545–3551, 2016. doi: 10. 1681/ASN.2015091070.
19. Gealekman O, Brodsky SV, Zhang F, Chander PN, Friedli C, Nasjletti A, Goligorsky MS. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. Kidney Int 66: 2337–2347, 2004. doi: 10.1111/j.1523-1755.2004.66035.x.
20. Goligorsky MS, Chen J, Brodsky S. Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension 37: 744–748, 2001. doi: 10.1161/01.HYP.37.2.744.
21. Goligorsky MS. Chronic kidney disease and vascular endothelium. In: Chronic Kidney Disease, edited by Kimmel P, Rosenberg M. New York, NY: Elsevier, 2015, chapt. 15, p. 170–180.
22. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392–395, 2009.
23. Hubbard BP, Sinclair DA. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci 35: 146–154, 2014. doi: 10.1016/j.tips.2013.12.004.
24. Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 170: 1473–1484, 2007. doi: 10.2353/ajpath. 2007.060481.
25. Kim BS, Chen J, Weinstein T, Noiri E, Goligorsky MS. VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. J Am Soc Nephrol 13: 2027–2036, 2002. doi: 10.1097/01.ASN.0000024436.00520.D8.
26. Kränkel N, Adams V, Linke A, Gielen S, Erbs S, Lenk K, Schuler G, Hambrecht R. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 25: 698–703, 2005. doi: 10.1161/01.ATV.0000156401.04325.8f.
27. Kumar Vr S, Darisipudi MN, Steiger S, Devarapu SK, Tato M, Kukarni OP, Mulay SR, Thomasova D, Popper B, Demleitner J, Zuchtriegel G, Reichel C, Cohen CD, Lindenmeyer MT, Liapis H, Moll S, Reid E, Stitt AW, Schott B, Gruner S, Haap W, Ebeling M, Hartmann G, Anders HJ. Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetic complications. J Am Soc Nephrol 27: 1635–1649, 2016. doi: 10.1681/ASN. 2015020208.
28. Lemkes BA, Nieuwdorp M, Hoekstra JB, Holleman F. The glycocalyx and cardiovascular disease in diabetes: should we judge the endothelium by its cover? Diabetes Technol Ther 14, Suppl 1: S3–S10, 2012. doi: 10. 1089/dia.2012.0011.
29. Lerman LO, Chade AR. Angiogenesis in the kidney: a new therapeutic target? Curr Opin Nephrol Hypertens 18: 160–165, 2009. doi: 10.1097/ MNH.0b013e32831ec1db.
30. Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Eichinger F, Gaiser S, Schmid H, Rastaldi MP, Schrier RW, Schlöndorff D, Cohen CD. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 18: 1765–1776, 2007. doi: 10.1681/ASN.2006121304.
31. Maezawa Y, Takemoto M, Yokote K. Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes. J Diabetes Investig 6: 3–15, 2015. doi: 10.1111/jdi.12255.
32. Mervaala E, Finckenberg P, Lapatto R, Müller DN, Park JK, Dechend R, Ganten D, Vapaatalo H, Luft FC. Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int 64: 501–508, 2003. doi: 10.1046/j.1523-1755.2003.00108.x.
33. Miyata T, Suzuki N, van Ypersele de Strihou C. Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology? Kidney Int 84: 693–702, 2013. doi: 10.1038/ki.2013.74.
34. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42: 263–285, 1999. doi: 10.1007/s001250051151.
35. Moroz N, Carmona JJ, Anderson E, Hart AC, Sinclair DA, Blackwell TK. Dietary restriction involves NAD-dependent mechanisms and a shift toward oxidative metabolism. Aging Cell 13: 1075–1085, 2014. doi: 10.1111/acel.12273.
36. Myrup B, Hansen PM, Jensen T, Kofoed-Enevoldsen A, Feldt-Rasmussen B, Gram J, Kluft C, Jespersen J, Deckert T. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345: 421–422, 1995. doi: 10.1016/S0140-6736 (95) 90403-4.
37. Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 61: 549–559, 2012. doi: 10.2337/ db11-1120.
38. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 16: 507–511, 2005. doi: 10.1097/ 01.mol.0000181325.08926.9c.
39. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, Kastelein JJ, Stroes ES, Vink H. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55: 1127–1132, 2006. doi: 10.2337/ diabetes.55.04.06.db05-1619.
40. Noiri E, Hu Y, Bahou WF, Keese CR, Giaever I, Goligorsky MS. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem 272: 1747–1752, 1997. doi: 10.1074/jbc. 272.3.1747.
41. Noiri E, Lee E, Testa J, Quigley J, Colflesh D, Keese CR, Giaever I, Goligorsky MS. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol Cell Physiol 274: C236–C244, 1998.
42. Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5: 194–222, 2015. doi: 10.3390/biom5010194.
43. Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes 64: 2289–2298, 2015. doi: 10.2337/db14-1820.
44. Patschan S, Chen J, Gealekman O, Krupincza K, Wang M, Shu L, Shayman JA, Goligorsky MS. Mapping mechanisms and charting the time course of premature cell senescence and apoptosis: lysosomal dysfunction and ganglioside accumulation in endothelial cells. Am J Physiol Renal Physiol 294: F100–F109, 2008. doi: 10.1152/ajprenal.00261.2007.
45. Patschan S, Chen J, Polotskaia A, Mendelev N, Cheng J, Patschan D, Goligorsky MS. Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells. Am J Physiol Heart Circ Physiol 294: H1119–H1129, 2008. doi: 10.1152/ajpheart.00713.2007.
46. Patschan S, Goligorsky MS. Autophagy: The missing link between non-enzymatically glycated proteins inducing apoptosis and premature senescence of endothelial cells? Autophagy 4: 521–523, 2008. doi: 10. 4161/auto.5904.
47. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG; BEAM Study Investigators. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365: 327–336, 2011. doi: 10.1056/NEJMoa1105351.
48. Rabelink TJ, de Zeeuw D. The glycocalyx--linking albuminuria with renal and cardiovascular disease. Nat Rev Nephrol 11: 667–676, 2015. doi: 10.1038/nrneph.2015.162.
49. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 454: 345–359, 2007. doi: 10.1007/s00424-007-0212-8.
50. Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, Wenzel P, Münzel T, Keaney JF Jr. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 118: 1347–1357, 2008. doi: 10.1161/CIRCULATIONAHA.108.784289.
51. Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res 118: 1808–1829, 2016. doi: 10. 1161/CIRCRESAHA.116.306923.
52. Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 17: 3093–3104, 2006. doi: 10.1681/ASN.2006010064.
53. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, Bauersachs J. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56: 666–674, 2007. doi: 10.2337/db06-0699.
54. Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 56: 2155–2160, 2007. doi: 10.2337/db07-0019.
55. Turner JM, Bauer C, Abramowitz MK, Melamed ML, Hostetter TH. Treatment of chronic kidney disease. Kidney Int 81: 351–362, 2012. doi: 10.1038/ki.2011.380.
56. Verdin E. NADin aging, metabolism, and neurodegeneration. Science 350: 1208–1213, 2015. doi: 10.1126/science.aac4854.
57. Weil EJ, Lemley KV, Mason CC, Yee B, Jones LI, Blouch K, Lovato T, Richardson M, Myers BD, Nelson RG. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int 82: 1010–1017, 2012. doi: 10.1038/ki.2012.234.
58. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 9: 121–167, 2007. doi: 10.1146/annurev.bioeng.9.060906.151959.
59. Zafrani L, Payen D, Azoulay E, Ince C. The microcirculation of the septic kidney. Semin Nephrol 35: 75–84, 2015. doi: 10.1016/j. semnephrol.2015.01.008.
60. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17: 2664–2669, 2006. doi: 10.1681/ASN.2006070798.